SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-18-030739
Filing Date
2018-05-07
Accepted
2018-05-07 06:09:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D a18-12835_2sc13d.htm SC 13D 79291
  Complete submission text file 0001104659-18-030739.txt   80877
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filed by) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 OPPENHEIMER STREET REHOVOT L3 76701
Business Address 5 OPPENHEIMER STREET REHOVOT L3 76701 (925) 272-4991
SteadyMed Ltd. (Subject) CIK: 0001619087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88774 | Film No.: 18809609
SIC: 2834 Pharmaceutical Preparations